Exodus Point Capital Management, LP Crinetics Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$42.12 - $51.91 $3.67 Million - $4.53 Million	87,203 Added 299.47%	116,322 $5.21 Million
Q1 2024 May 14, 2024	BUY	$34.76 - $46.81 $6,256 - $8,425	180 Added 0.62%	29,119 $1.36 Million
Q3 2023 Nov 09, 2023	SELL	$15.97 - $30.59 $2.6 Million - $4.99 Million	-163,035 Reduced 84.93%	28,939 $861,000
Q2 2023 Aug 10, 2023	BUY	$15.73 - $23.6 $705,616 - $1.06 Million	44,858 Added 30.49%	191,974 $3.46 Million
Q1 2023 May 11, 2023	BUY	$15.31 - $21.1 $2.25 Million - $3.1 Million	147,116 New	147,116 $2.36 Million

241

79.6M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.94B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.